America's Hospitals and Health Systems

June 14, 2002

Dear Senator or Representative:

America's hospitals and health systems are writing to emphasize the importance of enacting Medicaid Disproportionate Share Hospital (DSH) legislation this year. We strongly support two bipartisan bills that address the adequacy of DSH, one of our nation's few sources of financing for care to the uninsured and underinsured.



/B>

FOR IMMEDIATE RELEASE

P02-20

June 14, 2002

Print Media: 301-436-2335

Consumer Inquiries: 888-INFO-FDA

FDA INCREASES SAMPLING OF IMPORTED SHRIMP AND CRAYFISH (CRAWFISH)

The Food and Drug Administration (FDA) announced today that it will be increasing the sampling of imported shrimp and crayfish (also known as crawfish) for the presence of chloramphenicol. FDA is taking this action because low levels of chloramphenicol have been detected by some states and other countries in imported shrimp and crayfish.



Inside CMS has obtained a copy of several sections of the House GOP Medicare reform bill, scheduled to be unveiled by Republicans today.



/index.php?option=com_iwpfile&file=/dir_01/he2002_1733.pdf


on

Two Senate Finance Committee leaders are calling on Senate Appropriations Committee chair Robert Byrd (D-WV) to "vigorously oppose" the inclusion of a Medicare provision Congress' final 2002 supplemental appropriations bill. Finance Committee Chairman Max Baucus (D-MT) and ranking member Chuck Grassley (R-IA) say the items come under the jurisdiction of their committee. The committee leaders also sent a May 23 letter to Senate appropriators on the hospital reclassification provision.



/index.php?option=com_iwpfile&file=/dir_01/he2002_1730.pdf




on

FOR IMMEDIATE RELEASE

Friday, June 14, 2002

Contact:

FDA Press Office

(301) 827-6242

HHS ANNOUNCES PLANS TO STUDY EPHEDRA;

STEPS UP ENFORCEMENT OF ILLEGAL EPHEDRINE MARKETING



dice"

June 14, 2002

Contact: Angela Bradbery (202) 588-7741

Shannon Little (202) 588-7742

Statement by Sidney M. Wolfe, M.D.

Director, Public Citizen's Health Research Group

Concerning HHS Failure to Ban Ephedra or Issue Adequate Warnings



/index.php?option=com_iwpfile&file=/dir_01/he2002_1729.pdf


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.